Literature DB >> 3456198

Cutaneous malignant melanoma and familial dysplastic nevi: evidence for autosomal dominance and pleiotropy.

S J Bale, A Chakravarti, M H Greene.   

Abstract

Segregation of familial cutaneous melanoma has been shown to be compatible with autosomal dominant transmission with incomplete penetrance. However, the combined phenotype of melanoma and a known melanoma-precursor lesion, the dysplastic nevus (DN), has not previously been found to fit a Mendelian model of inheritance using complex segregation analysis. Employing a life-table and disease-free survival analysis approach, we estimated the lifetime incidence of melanoma in the sibs and offspring of DN-affected individuals to be 46%, consistent with a highly penetrant, autosomal dominant mode of inheritance. To further elucidate the relationship between the two traits, we conducted a linkage analysis between the melanoma locus and a hypothetical DN locus, and obtained a maximum lod score of 3.857 at theta = .08. Furthermore, all families giving evidence for linkage were in the coupling phase and the maximum likelihood estimate of theta was not significantly different from 0 (P = .1). This provides evidence that the DN and melanoma traits may represent pleiotropic effects of a single, highly penetrant gene behaving in an autosomal dominant manner.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456198      PMCID: PMC1684756     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  30 in total

1.  A computer program for linkage analysis of general human pedigrees.

Authors:  J Ott
Journal:  Am J Hum Genet       Date:  1976-09       Impact factor: 11.025

2.  Heredity and malignant melanoma: implications for early cancer detection.

Authors:  H T Lynch; A J Krush
Journal:  Can Med Assoc J       Date:  1968-07-06       Impact factor: 8.262

3.  Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature.

Authors:  M H Greene; W H Clark; M A Tucker; D E Elder; K H Kraemer; M C Fraser; E E Bondi; D Guerry; R Tuthill; R Hamilton; D LaRossa
Journal:  Lancet       Date:  1980-11-08       Impact factor: 79.321

4.  [BK-mole syndrome].

Authors:  O Braun-Falco; M Landthaler; F Ryckmanns
Journal:  Fortschr Med       Date:  1979-09-20

5.  [Is the BK mole syndrome always an autosomal dominant trait?].

Authors:  R Bovet; B Bachmann; J Delacrétaz
Journal:  Ann Dermatol Venereol       Date:  1980       Impact factor: 0.777

6.  Hereditary aspects of malignant melanoma.

Authors:  D E Anderson; J L Smith; C M McBride
Journal:  JAMA       Date:  1967-05-29       Impact factor: 56.272

7.  Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome.

Authors:  R R Reimer; W H Clark; M H Greene; A M Ainsworth; J F Fraumeni
Journal:  JAMA       Date:  1978-02-20       Impact factor: 56.272

8.  Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'.

Authors:  W H Clark; R R Reimer; M Greene; A M Ainsworth; M J Mastrangelo
Journal:  Arch Dermatol       Date:  1978-05

9.  Familial atypical multiple mole-melanoma syndrome.

Authors:  H T Lynch; B C Frichot; J F Lynch
Journal:  J Med Genet       Date:  1978-10       Impact factor: 6.318

10.  [Familial malignant melanoma and atypical disseminated moles (BK-mole syndrome)].

Authors:  M Hundeiker; R Ruppel; H Schmitt
Journal:  Hautarzt       Date:  1980-01       Impact factor: 0.751

View more
  15 in total

1.  Structural alteration in the MYB protooncogene and deletion within the gene encoding alpha-type protein kinase C in human melanoma cell lines.

Authors:  A J Linnenbach; K Huebner; E P Reddy; M Herlyn; A H Parmiter; P C Nowell; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

2.  Analysis of chromosomal imbalances in an elderly woman with a giant cell tumour.

Authors:  Juan Luis García; Cristina Robledo; E Lumbreras; Teresa Flores; Luis Ramos; Jesús M Hernández
Journal:  Virchows Arch       Date:  2005-10-12       Impact factor: 4.064

3.  Evidence for autosomal dominance and pleiotropy of the cutaneous malignant melanoma (CMM)/Dysplastic nevus (DN) gene.

Authors:  S J Bale; A Chakravarti
Journal:  Am J Hum Genet       Date:  1987-05       Impact factor: 11.025

4.  Mammary epithelial hyperplasias: alterations related solely to proliferation?

Authors:  R R Burbano; J B Neto; P M Philbert; C Casartelli
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  The inheritance of cutaneous malignant melanoma (CMM) and dysplastic nevus syndrome (DNS).

Authors:  L Pascoe
Journal:  Am J Hum Genet       Date:  1987-05       Impact factor: 11.025

6.  Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity.

Authors:  A M Goldstein; N C Dracopoli; E C Ho; M C Fraser; K S Kearns; S J Bale; O W McBride; W H Clark; M A Tucker
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

Review 7.  Molecular aspects of melanocytic dysplastic nevi.

Authors:  Mahmoud Rezk Abd-Elwahed Hussein; Gary Stewart Wood
Journal:  J Mol Diagn       Date:  2002-05       Impact factor: 5.568

8.  Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression.

Authors:  N C Dracopoli; P Harnett; S J Bale; B Z Stanger; M A Tucker; D E Housman; R F Kefford
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

Review 9.  Hereditary melanoma and the search for the melanoma gene.

Authors:  R F Kefford
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

10.  Thymine dimer repair in fibroblasts of patients with dysplastic naevus syndrome (DNS).

Authors:  M Roth; J M Boyle; H Müller
Journal:  Experientia       Date:  1988-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.